Preparation and characterization of tamoxifen citrate loaded nanoparticles for breast cancer therapy

International Journal of Nanomedicine

Volumn 9, Issue 1, 2015, Pages 3107-3118

  Maji, Ruma ^a   Dey, Niladri Shekhar ^a   Satapathy, Bhabani Sankar ^a   Mukherjee, Biswajit ^a   Mondal, Subhasish ^a  

^a JADAVPUR UNIVERSITY   (India)

Author keywords

Breast cancer; Multiple emulsion; PLGA; Polylactide co glycolide nanoparticle

Indexed keywords

NANOPARTICLE; POLYGLACTIN; TAMOXIFEN CITRATE; ANTINEOPLASTIC AGENT; EMULSION; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER THERAPY; CELL TRANSPORT; CELL VIABILITY; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; DRUG DISTRIBUTION; DRUG FORMULATION; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; MCF 7 CELL LINE; PARTICLE SIZE; PHYSICAL CHEMISTRY; SUSTAINED DRUG RELEASE; ZETA POTENTIAL; BREAST TUMOR; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; ELECTRON MICROSCOPY; EMULSION; FEMALE; SURFACE PROPERTY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; EMULSIONS; FEMALE; HUMANS; LACTIC ACID; MICROSCOPY, ELECTRON; NANOPARTICLES; PARTICLE SIZE; POLYGLYCOLIC ACID; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE PROPERTIES; TAMOXIFEN;

EID: 84903385989     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S63535     Document Type: Article

References (34)

1. Malik AA, Wani KA, Ahmad SR. Breast conservative therapy. J Med Sci. 2012;15(1):7-14.
2. Sinha R, Kim GJ, Nie S, Shin DM. Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Mol Cancer Ther. 2006;5(8):1909-1917.
3. Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Préat V. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release. 2012;161(2):505-522.
4. Lü JM, Wang X, Marin-Muller C, et al. Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagn. 2009;9(4):325-341.
5. Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces. 2010;75(1):1-18.
6. Prokop A, Davidson JM. Nanovehicular intracellular delivery systems. J Pharm Sci. 2008;97(9):3518-3590.
7. Averineni RK, Shavi GV, Gurram AK, et al. PLGA 50:50 nanoparticles of paclitaxel: Development, in vitro anti-tumor activity in BT-549 cells and in vivo evaluation. Bull Mater Sci. 2012;35(3):319-326.
8. Hassani SM, Bagheri S. Computational procedure for determining physicochemical properties of doxorubicin-PLGA nanoparticles and daunorubicin-PLGA nanoparticles. Int J Pharm Tech Res. 2012;4(3): 1242-1246.
9. Pradhan R, Poudel BK, Ramasamy T, Choi HG, Yong CS, Kim JO. Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: formulation, physicochemical characterization and cytotoxicity studies. J Nanosci Nanotechnol. 2013;13(8):5948-5956.
10. Wohlfart S, Khalansky AS, Gelperina S, et al. Efficient chemotherapy of rat glioblastoma using doxorubicin-loaded PLGA nanoparticles with different stabilizers. PLoS One. 2011;6(5):e19121.
11. The BIG 1-98 Collaborative Group. Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer. N Engl J Med. 2009;361(8):766-776.
12. Peters-Engl C, Frank W, Danmayr E, Friedl HP, Leodolter S, Medl M. Association between endometrial cancer and tamoxifen treatment of breast cancer. Breast Cancer Res Treat.1999;54(3):255-260.
13. de Lima GR, Facina G, Shida JY, et al. Effects of low dose tamoxifen on normal breast tissue from premenopausal women. Eur J Cancer. 2003;39(7):891-898.
14. Mirzajani F, Rafati H, Atyabi F. Fabrication of biodegradable poly (d, l-lactide-co-glycolide) nanoparticles containing tamoxifen citrate. Iranian Polymer Journal. 2010;19(6):437-446.
15. Lamprecht A, Ubrich N, Hombreiro Pérez M, Lehr CM, Hoffman M, Maincent P. Biodegradable monodispersed nanoparticles prepared by pressure homogenization-emulsification. Int J Pharm. 1999;184(1): 97-105.
16. Ueda M, Kreuter J. Optimization of the preparation of loperamide-loaded poly (L-lactide) nanoparticles by high pressure emulsification-solvent evaporation. J Microencapsul. 1997;14(5):593-605.
17. Sinha B, Mukherjee B, Pattnaik G. Poly-lactide-co-glycolide nanoparticles containing voriconazole for pulmonary delivery: in vitro and in vivo study. Nanomedicine. 2013;9(1):94-104.
18. Li X, Tian X, Zhang J, et al. In vitro and in vivo evaluation of folate receptor-targeting amphiphilic copolymer-modified liposomes loaded with docetaxel. Int J Nanomedicine. 2011;6:1167-1184.
19. Fonseca C, Simõesa S, Gaspar R. Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity. J Control Release. 2002;83(2):273-286.
20. Rudra A, Manasadeepa R, Ghosh MK, Ghosh S, Mukherjee B. Doxorubicin-loaded phosphatidylethanolamine-conjugated nanoliposomes: in vitro characterization and their accumulation in liver, kidneys, and lungs in rats. Int J Nanomedicine. 2010;5:811-823.
21. Beckett AH, Stenlake JB. Infrared spectrophotometry. In: Practical pharmaceutical chemistry. 4th ed. Part 2. CBS Publishers, India: New Delhi; 1997:384-390.
22. Sahana B, Santra K, Basu S, Mukherjee B. Development of biodegradable polymer based tamoxifen citrate loaded nanoparticles and effect of some manufacturing process parameters on them: a physicochemical and in-vitro evaluation. Int J Nanomedicine. 2010;5:621-630.
23. Meißner T, Potthoff A, Richter V. Suspension characterization as important key for toxicological investigations. J Phys Conf Ser. 2009;170(1).
24. Basu S, Mukherjee B, Chowdhury SR, et al. Colloidal gold-loaded, biodegradable, polymer-based stavudine nanoparticle uptake by macrophages: an in vitro study. Int J Nanomedicine. 2012;7:6049-6061.
25. Nayak AK, Pal D. Development of pH-sensitive tamarind seed polysaccharide-alginate composite beads for controlled diclofenac sodium delivery using response surface methodology. Int J Biol Macromol. 2011;49(4):784-793.
26. Pattnaik G, Sinha B, Mukherjee B, et al. Submicron-size biodegradable polymer-based didanosine particles for treating HIV at early stage: an in vitro study. J Microencapsul. 2012;29(7):666-676.
27. Mukherjee B, Roy G, Santra K, Sahana B. Lactide-glycolide polymers as nanodimensional carriers for drugs. Int J Biomed Nanosci Nanotechnol. 2010;1:230-246.
28. Kocbek P, Obermajer N, Cegnar M, Kos J, Kristl J. Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody. J Contol Release. 2007;120(1-2):18-26.
29. Li X, Li R, Qian X, et al. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate. Euro J Pharm Biopharm. 2008;70(3):726-734.
30. Zhang L, Yang M, Wang Q, et al. 10-Hydroxycamptothecin loaded nanoparticles: preparation and antitumor activity in mice. J Control Release. 2007;119(2):153-162.
31. Zhang L, Hu Y, Jiang X, Yang C, Lu W, Yang YH. Camptothecin derivative-loaded poly(caprolactone-co-lactide)- b-PEG-b-poly(caprolactone-co-lactide) nanoparticles and their biodistribution in mice. J Control Release. 2004;96(1):135-148.
32. Bae YH, Park K. Targeted drug delivery to tumors: myths, reality and possibility. J Control Release. 2011;153(3):198-205.
33. Cirpanli Y, Yerlikaya F, Ozturk K, et al. Comparative evaluation of in vitro parameters of tamoxifen citrate loaded poly(lactide-co-glycolide), poly(epsilon-caprolactone) and chitosan nanoparticles. Pharmazie. 2010;65(12):867-870.
34. Unger F, Wittmar M, Kissel T. Branched polyesters based on poly [vinyl-3-(dialkylamino) alkylcarbamate-co-vinyl acetate-co-vinyl alcohol]-graft-poly (d, l-lactide-co-glycolide): Effects of polymer structure on cytotoxicity. Biomaterials. 2007;28(9):1610-1619.